Metrics In Balance NV (XPAR:MLMIB) EBIT: €0.02 Mil (TTM As of Dec. 2024)


XPAR:MLMIB Metrics In Balance NV XPAR:MLMIB
4 GF Score
Price €0.03
! 3 Warning Signs
View Full Analysis

What is Metrics In Balance NV EBIT?

Metrics In Balance NV XPAR:MLMIB 4 EBIT is €0.02 Mil as of Dec. 2024. GuruFocus rates XPAR:MLMIB with a GF Score™ of 4/100. The stock has 3 warning signs investors should review.

Metrics In Balance NV's earnings before interest and taxes (EBIT) for the six months ended in Dec. 2024 was €0.02 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2024 was €0.02 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Metrics In Balance NV's annualized ROC % for the quarter that ended in Dec. 2024 was -0.12%. Metrics In Balance NV's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2024 was 160.00%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Metrics In Balance NV's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2024 was 2.34%.

Metrics In Balance NV  (XPAR:MLMIB) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Metrics In Balance NV's annualized ROC % for the quarter that ended in Dec. 2024 is calculated as:

ROC % (Q: Dec. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2023 ) + Invested Capital (Q: Dec. 2024 ))/ count )
=-0.015 * ( 1 - 0% )/( (12.842 + 13.012)/ 2 )
=-0.015/12.927
=-0.12 %

where

Invested Capital(Q: Dec. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=12.543 - 0.134 - ( 0 - max(0, 0.684 - 0.251+0))
=12.842

Invested Capital(Q: Dec. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=12.617 - 0.077 - ( 0 - max(0, 0.828 - 0.356+0))
=13.012

Note: The Operating Income data used here is one times the annual (Dec. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Metrics In Balance NV's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2023  Q: Dec. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=0.024/( ( (0.03 + max(-0.396, 0)) + (0 + max(-0.597, 0)) )/ 2 )
=0.024/( ( 0.03 + 0 )/ 2 )
=0.024/0.015
=160.00 %

where Working Capital is:

Working Capital(Q: Dec. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.233 + 0.015 + 0) - (0.134 + 0 + 0.51)
=-0.396

Working Capital(Q: Dec. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.181 + 0.009 + 0) - (0.077 + 0 + 0.71)
=-0.597

When net working capital is negative, 0 is used.

Note: The EBIT data used here is one times the annual (Dec. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Metrics In Balance NV's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2024 )
=0.024/1.025
=2.34 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Metrics In Balance NV EBIT Related Terms

Metrics In Balance NV EBIT Historical Data

* Premium members only.

The historical data trend for Metrics In Balance NV's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Metrics In Balance NV EBIT Chart

Metrics In Balance NV Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EBIT
Get a 7-Day Free Trial 0.00 0.01 -0.05 -0.04 0.02

Metrics In Balance NV Semi-Annual Data
Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EBIT Get a 7-Day Free Trial 0.00 0.01 -0.05 -0.04 0.02

XPAR:MLMIB vs MCK, COR, CAH: EBIT Comparison

For the Medical Distribution subindustry, Metrics In Balance NV's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Metrics In Balance NV EV-to-EBIT vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Metrics In Balance NV's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Metrics In Balance NV's EV-to-EBIT falls into.


XPAR:MLMIB
4GF Score
Metrics In Balance NV XPAR:MLMIB
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Metrics In Balance NV EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. EBIT for the trailing twelve months (TTM) ended in Dec. 2024 was €0.02 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of €0.02 Mil mean?
Metrics In Balance NV (XPAR:MLMIB) has a EBIT of €0.02 Mil as of Dec. 2024. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Metrics In Balance NV.
Is Metrics In Balance NV's EBIT too high?
Metrics In Balance NV's current EBIT is €0.02 Mil. Overall, Metrics In Balance NV has a GF Score™ of 4/100, reflecting its overall financial health beyond just this single metric.
How does Metrics In Balance NV's EBIT compare to MCK and COR?
Metrics In Balance NV's EBIT of €0.02 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Medical Distribution company?
A good EBIT depends on the Medical Distribution industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Metrics In Balance NV. Metrics In Balance NV's current EBIT is €0.02 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Metrics In Balance NV stock overvalued right now?
Metrics In Balance NV (XPAR:MLMIB) has a current EBIT of €0.02 Mil. The current EBIT is €0.02 Mil. Metrics In Balance NV's overall GF Score™ is 4/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Metrics In Balance NV (XPAR:MLMIB), the current EBIT is €0.02 Mil as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Metrics In Balance NV Business Description

Address Regenboog 1, Melle, BEL, 9090
Metrics In Balance NV is engaged in the sale of medical devices for the measurement, diagnosis, and resolution of disorders related to dental occlusion malfunction.
4GF Score

Get the complete analysis for XPAR:MLMIB

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.03
Price